Repligen Corporation (RGEN)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 32,996 19,161 27,554 38,061 68,521 119,771 157,762 192,856 217,954 202,321 196,417 187,635 166,257 150,374 127,027 99,062 74,757 58,442 45,615 38,301
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 2,016,690 2,016,690 1,986,360 1,970,600 1,971,200 464,337 446,165 426,101 397,272 1,835,110 1,805,360 1,766,400 1,750,070 1,715,260 131,452 95,219 65,769 1,124,870 1,100,030 1,069,760
Return on total capital 1.64% 0.95% 1.39% 1.93% 3.48% 25.79% 35.36% 45.26% 54.86% 11.03% 10.88% 10.62% 9.50% 8.77% 96.63% 104.04% 113.67% 5.20% 4.15% 3.58%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $32,996K ÷ ($—K + $2,016,690K)
= 1.64%

Repligen Corporation's return on total capital has shown some variability over the past few years. From March 31, 2020, to June 30, 2022, the return on total capital improved steadily, reaching a peak of 11.03% on September 30, 2022. Subsequently, there was a significant decrease in the return on total capital to 3.48% by December 31, 2023. This decline continued into the next reporting periods, with returns ranging between 0.95% to 1.93%.

The data suggests that Repligen Corporation experienced a period of high return on total capital in 2021 and 2022, followed by a notable decline in subsequent years. This could indicate fluctuations in the company's capital efficiency and profitability during this timeframe.

It would be advisable for stakeholders and investors to closely monitor the company's performance and assess the factors contributing to the fluctuations in return on total capital to make informed decisions about the company's financial health and prospects.